Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China.
Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China; Fujian Key Laboratory of Aptamers Technology, The 900(th) Hospital of Joint Logistics Support Force, Fuzhou 350025, China.
J Adv Res. 2023 Jan;43:73-85. doi: 10.1016/j.jare.2022.03.001. Epub 2022 Mar 4.
MicroRNAs (miRNAs) have been revealed to be critical genetic regulators in various physiological processes and thus quantitative information on the expression level of critical miRNAs has important implications for the initiation and development of human diseases, including cancers.
We herein develop three-dimensionally (3D) counting of intracellular fluorescent spots for accurately evaluating microRNA-21 (miRNA-21) expression in individual HeLa cells based on stimuli-activated in situ growth of optical DNA flares, grid-patterned DNA-protein hybrids (GDPHs).
Target miRNA is sequence-specifically detected down to 10 pM owing to efficient signal amplification. Within living cells, GDPH flares are nuclease resistant and discrete objects with retarded mobility, enabling the screening of intracellular location and distribution of miRNAs and realizing in situ counting of target species with a high accuracy.
The quantitative results of intracellular miRNAs by 3D fluorescence counts are consistent with qPCR gold standard assay, exhibiting the superiority over 2D counts. By screening the expression of intracellular miR-21 that can down-regulate the programmed cell death 4 (PDCD4) protein, the proliferation and migration of HeLa cells, including artificially-regulated ones, were well estimated, thus enabling the prediction of cancer metastasis in murine tumor models.
The experiments in vitro, ex vivo and in vivo demonstrate that GDPH-based 3D fluorescence counts at the single cell level provide a valuable molecular tool for understanding biological function of miRNAs and especially for recognizing aggressive CTCs, offering a design blueprint for further expansion of DNA structural nanotechnology in predicting distant metastasis and prevention of tumor recurrence after primary resection.
微小 RNA(miRNA)已被揭示为各种生理过程中的关键遗传调节剂,因此关键 miRNA 表达水平的定量信息对人类疾病(包括癌症)的发生和发展具有重要意义。
我们在此基于光学 DNA 闪烁物的刺激激活原位生长,开发了一种用于在单个 HeLa 细胞中准确评估 miRNA-21(miRNA-21)表达的三维(3D)荧光点计数方法,即网格图案 DNA-蛋白质杂合体(GDPH)。
由于高效的信号放大,目标 miRNA 可以在低至 10 pM 的浓度下进行序列特异性检测。在活细胞内,GDPH 闪烁物是具有抗核酸酶性和离散性的物体,且迁移率降低,这使得能够筛选细胞内 miRNA 的位置和分布,并实现对目标物的原位高精度计数。
通过 3D 荧光计数获得的细胞内 miRNA 的定量结果与 qPCR 金标准检测结果一致,优于 2D 计数。通过筛选能够下调程序性细胞死亡 4(PDCD4)蛋白的细胞内 miR-21 的表达,能够很好地评估包括人工调控的 HeLa 细胞的增殖和迁移,从而能够预测小鼠肿瘤模型中的癌症转移。
体外、离体和体内实验表明,基于 GDPH 的 3D 荧光单细胞计数为理解 miRNA 的生物学功能提供了有价值的分子工具,特别是对于识别侵袭性循环肿瘤细胞(CTC),为进一步扩展 DNA 结构纳米技术在预测远处转移和预防原发性切除后肿瘤复发方面提供了设计蓝图。